News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Forgoing radiotherapy possible for select postmenopausal women with early breast cancer
10 Jan 2024
byJairia Dela Cruz
For postmenopausal women with genomically defined low-risk stage I breast cancer who have been initiated on endocrine therapy immediately after breast-conserving surgery, the risk of recurrence is low despite the omission of radiation therapy, as shown in the IDEA* trial.
Forgoing radiotherapy possible for select postmenopausal women with early breast cancer
10 Jan 2024
Add-on carfilzomib yields benefits in transplant-ineligible NDMM patients
10 Jan 2024
byAudrey Abella
The addition of carfilzomib to lenalidomide and dexamethasone (KRd) improved outcomes in individuals with newly diagnosed fit or intermediate-fit multiple myeloma who are transplant ineligible (NTE NDMM) as opposed to Rd only in the phase III EMN20 trial.







